Eli Lilly stock down 19% in May, on track for worst month since 2009. But June historically brings better fortune, with 67% chance of closing higher.

Vertex and Eli Lilly are revolutionizing non-opioid pain management with NaV1.8 advancements. See why I'm bullish about LLY ...

Global drugmakers, including generic drug manufacturers in India, are racing to develop their versions of blockbuster ...

Eli Lilly's (NYSE: LLY) share price soared during ... Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription ...

The success of Eli Lilly & Co.'s weight-loss and diabetes drugs ... a professor at Kean University who has edited a book on Indiana philanthropy. The endowment has helped build networks for ...

Village Health Workers in Zimbabwe use digital medical equipment and smartphones to diagnose and treat childhood ...

Looking at licensing deals struck in the past 10 years, Jefferies found that many Big Pharmas do not ultimately follow ...

The Global Entrepreneurship Congress kicked of Monday with a discussion led by Gov. Mike Braun and companies including Eli ...

The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and ...